CardioDetect is the first rapid test worldwide using the highly specific early marker h-FABP. The fast bedside test CardioDetect allows to take full advantage of fast h-FABP for a significantly earlier diagnosis of AMI.
CardioDetect can be used directly with whole blood, serum or plasma.
A range of versions is available covering the various areas of application.
The tests are ideally suited for emergency units like ambulances, emergency rooms, first aid departments, rescue units as well as offices of general practitioners and cardiologists.
Furthermore they are helpful for all institutions taking care of risk persons, e.g. cardiology departments, rehabilitation centres, old people's and nursing homes.
The new reader CardioDetect quant provides quantifications of the h-FABP concentration extremely fast and cost effective.
All our products have CE approval. Our production is in accordance with GMP as specified in ISO 13485:2003.
Specifications:
- CardioDetect med
- - detects h-FABP in whole blood, serum or plasma
- CardioDetect combi
- - detects h-FABP in whole blood, serum or plasma and additionally the late marker Troponin I
- CardioDetect lab
- - detects h-FABP in serum or plasma
- CardioDetect self
- - detects h-FABP in whole blood, serum or plasma, specifically designed for home use by risk patients
Ordering information:
- Minimum Order: Negotiable